Sem-P Prefilled Pen (Semaglutide)

Sem-P Pen is a once-weekly injectable biosimilar of semaglutide, designed to support weight loss, improve blood sugar control, and reduce long-term risks associated with type 2 diabetes, obesity, and related conditions. Backed by clinical trials and ADA 2025 guidelines, Sem-P Pen delivers powerful metabolic benefits in a convenient prefilled pen.

Sem-P Pen works by activating GLP-1 and GIP receptors, which regulate appetite, insulin secretion, and energy use. This dual action helps:

• Suppress hunger and promote satiety
• Enhance insulin sensitivity and glucose control
• Support gradual, sustained weight loss
• Reduce inflammation and improve liver function

Sem-P® is administered once weekly via subcutaneous injection using a prefilled pen.

Dosing Schedule:

• Weeks 1–4: Start with 0.25 mg
• Weeks 5–8: Escalate to and maintain at 0.5 mg
• Week 9 onward: Maintain at 1.0 mg

Available Strengths:

• 2 mg/1.5 mL (delivers 0.25 mg and 0.5 mg increments)
• 4 mg/3 mL (delivers 1 mg increments)

Always follow your doctor’s instructions. Store as directed and use only under medical supervision.

To be sold on the prescription of a registered medical practitioner only.